The growing noncommunicable disease burden, a challenge for the countries of the Americas.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to J Litvak.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
A multidisciplinary approach to cancer control, diagnosis, pretreatment evaluation and particularly treatment requires cooperation among surgeons, internists, chemotherapists and radiotherapists. The best sequence of radiotherapy and chemotherapy in patients who need both treatments is essential to avoid interference between treatments or potentiation of the adverse toxic effects. Several features may interfere in the detection and delivery of the best treatment combination in patients with cancer in Latin American countries, compared to patients in more developed countries: (1) There are differences among countries in the percentages for certain cancer sites and stages of disease. (2) Most of the cancer incidence figures are originated in hospital-based registries and not population-based registries. (3) On many occasions the modality of treatment of an individual patient depends on which doctor the patient sees first--the physician, the surgeon, or the radiotherapist. (4) In many radiotherapy services the treatment capacity is outweighed by the great amount of cancer patients, and radiotherapy is used primarily for curative purposes. (5) A higher percentage of patients arrive with advanced incurable disease because of lack of the awareness of the significance of early signs and symptoms on the part of patients, relatives and even doctors. (6) Another frequent problem is the lack of communication, transportation and accommodations near the treatment center. Many patients come from long distances; these factors make adequate follow-up of patients difficult. (7) There is a lack of radiotherapy services and there are numerous non-functioning units due to break-downs. A collaborative cancer treatment research program was initiated in 1977 between Latin American cancer centers and U.S. centers. This program is coordinated by the Pan American Health Organization and U.S. National Cancer Institute. Most of the protocols include multiple modality treatment (surgery, radiotherapy, chemotherapy and immunotherapy). This program has shown that, good control clinical trials can be performed in multiple cancer centers in Latin America in spite of the problems mentioned above.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
PAHO recently convened a meeting of experts on diabetes mellitus for purposes of underlining the importance of the disease as a health problem and developing recommendations to assist the countries of the Region in establishing control programs. Existing data on the prevalence of diabetes mellitus in different countries are not comparable, since population samples are not always representative and diagnostic criteria vary. Ten different countries set the prevalence figure at anywhere from 1.2 to 6.9 per cent. Mortality from diabetes reveals only part of the problem, largely because of registration difficulties. The figures that are available, however, show that the situation is very serious in several Carribbean countries; that is, Barbados, Trinidad and Tobago, and Jamaica rank first, second, and third, respectively, among 22 countries in the Americas. The data now available on morbidity and mortality, expected population growth, and probably increases in the relative size of older population groups lead to the assumption that diabetes mellitus, together with its complications, will become an increasingly serious problem in the Region over the next 10 to 15 years. Programs for the control of diabetes mellitus should include educational campaigns for patients, the public, and health professionals; early detection of the disease in high-risk groups; registration and followup of cases and the organization of systems for providing comprehensive care. Promotion of basic, clinical, and epidemiologic research directed at local problems and seeking to acquire a better understanding of the nature of the disease and its complications is also highly recommended. Naturally, each country should adapt current methods of treatment to local socioeconomic and cultural circumstances, especially with regard to dietary therapy, prescribed insulin dosage, and use of the controversial oral hypoglycemic drugs. Despite the important contribution that research can make to a better understanding of diabetes mellitus, it is the health authorities, the patients, and the public who still have the major task of coping with this increasingly prevalent disease, which more and more is revealing the consequences of its chronic nature and complications in our Region.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.